-
ARCA Cy3 EGFP mRNA: Assay Design Guide
2026-08-18
ARCA Cy3 EGFP mRNA (5-moUTP) enables researchers to separate cellular uptake, intracellular trafficking, and translation in mammalian-cell delivery assays. This mechanistic guide shows how to use its Cy3 and EGFP signals to interpret delivery performance rather than simply measure transfection intensity.
-
Cy5-UTP RNA Labeling: Workflow & Troubleshooting
2026-08-18
Cy5-UTP enables direct, far-red visualization of RNA produced by T7 in vitro transcription, with practical advantages for FISH, multiplex assays, and array workflows. This guide connects probe synthesis and quality control with emerging mRNA nanoparticle studies while clearly separating validated product use from exploratory delivery applications.
-
Thymosin-β4, Notch/NF-κB, and Limb Ischemia
2026-08-17
The reference study identifies a mechanistic link between thymosin-β4 and therapeutic angiogenesis in critical limb ischemia, connecting Notch activation with NF-κB signaling in endothelial cells and ischemic muscle. Its combined cell, animal, pharmacological inhibition, and molecular readouts provide a useful framework for evaluating pathway-dependent vascular repair while also highlighting limits of overexpression and inhibitor-based evidence.
-
LDH Cytotoxicity Assay Kit: Practical Workflow
2026-08-17
The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive approach to cell cytotoxicity measurement by quantifying LDH released into culture medium after membrane damage. It is suitable for comparative cell damage quantification and cytotoxicity screening, but LDH release alone should not be used to assign a specific death mechanism such as apoptosis.
-
SR 11302: AP-1 Signaling in Tumor Immunity
2026-08-16
SR 11302 is an AP-1 transcription factor inhibitor for dissecting how oncogenic transcription intersects with macrophage biology. This article interprets the compound as a mechanistic probe for tumor–immune assays, with practical guidance grounded in colorectal cancer research.
-
Standardized Whole-Blood Stimulation and Immunometabolism
2026-08-15
Zhao and colleagues present a standardized whole-blood stimulation protocol for testing how metabolic interventions reshape human immune responses. By combining defined immune stimuli, pathway-directed inhibitors, matched controls, and cytokine measurements, the workflow supports more reproducible immunometabolism studies while preserving the complexity of whole blood.
-
Estrogen–ERα/KRT19 Signaling in Papillary Thyroid Cancer
2026-08-14
This study integrates public transcriptomic analysis, Oxford Nanopore sequencing, cell perturbation experiments, and xenograft validation to examine how estrogen promotes papillary thyroid carcinoma. Its central finding is that estrogen receptor α activation engages KRT19 to support tumor-cell proliferation, migration, and invasion, while also highlighting important limits in translating this axis to patients.
-
tFUS, Nespas/miR-383-3p, and SHP2 After Stroke
2026-08-14
The reference study identifies a mechanistic link between low-intensity transcranial focused ultrasound and suppression of NLRP3-driven neuroinflammation after ischemic stroke. Its rat and microglial-cell experiments place the Nespas/miR-383-3p/SHP2 axis between neuromodulation and inflammasome regulation, providing a framework for testing SHP2-dependent microglial responses.
-
Plerixafor (AMD3100): CXCR4 Workflow Guide
2026-08-13
Plerixafor (AMD3100) provides a reversible way to interrogate CXCL12/CXCR4 signaling in tumor trafficking, stem cell release, and inflammatory cell movement. This practical guide connects concentration-controlled assays with the reference study’s platelet-extravasation findings, emphasizing workflow design, controls, and troubleshooting.
-
Chlorambucil: In Vitro Assay Workflows
2026-08-13
Chlorambucil is a practical DNA crosslinking model for separating growth arrest from true cell killing in cancer research. This workflow combines solvent control, time-resolved viability measurements, and orthogonal apoptosis assessment for more interpretable CLL, glioma, endothelial, and developmental cell studies.
-
Recombinant Human FGF-19 Assay Workflows
2026-08-12
Build cleaner FGFR4/β-Klotho signaling experiments with a tag-free, E. coli-expressed ligand and orthogonal binding, proliferation, and metabolic readouts. This guide connects practical FGF-19 workflow design with time-resolved stress-signaling assays inspired by recent renal pyroptosis research, while clearly separating validated applications from exploratory extensions.
-
Ranolazine Workflows for Cardiac Ischemia Research
2026-08-12
Ranolazine supports experimentally distinct studies of late sodium current, myocardial relaxation, and metabolic substrate use. This guide translates its anti-ischemic action into practical cardiac and hepatic workflows while clearly separating established product information, assay recommendations, and cross-domain hypotheses.
-
Recombinant Annexin V for Apoptosis Detection
2026-08-11
The reference study established a practical bacterial-expression and purification workflow for soluble, polyhistidine-tagged Annexin V, then adapted the protein for FITC labeling and apoptotic-cell analysis. Its main contribution is methodological: it connects scalable recombinant production with flow-cytometric and fluorescence-microscopy detection of phosphatidylserine externalization.
-
XPO1 Inhibition Combinations in Basal-Like TNBC
2026-08-11
This preclinical study used high-throughput drug screening, combination testing, patient-derived xenografts, and transcriptomic analyses to identify XPO1 inhibition as a rational strategy in basal-like triple-negative breast cancer. The strongest in vivo result came from combining KPT-330 with the PI3K/mTOR inhibitor GSK2126458, while XPO1 expression was linked to proliferative and metastatic features.
-
LY2109761: From Smad Signals to Assay Design
2026-08-10
LY2109761 is a TGF-β receptor type I and II dual inhibitor that connects receptor kinase blockade with Smad signaling, cell-cycle control, and preclinical cancer and fibrosis models. This article translates the miR-424/503–CDC25A findings into practical assay strategies and interpretation safeguards.